Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ovarian neoplasm
|
757 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
polyps
|
18 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Primary differentiated carcinoma of thyroid gland
|
41 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.010 | 1 | 2011 | 2011 | ||||||
Rectal Carcinoma
|
112 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Secondary malignant neoplasm of lymph node
|
188 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Adult Liver Carcinoma
|
72 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.020 | 1.000 | 2 | 2008 | 2014 | |||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.020 | 1.000 | 2 | 2008 | 2014 | |||||
Malignant neoplasm of liver
|
88 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.020 | 1.000 | 2 | 2008 | 2014 | |||||
Papillary thyroid carcinoma
|
204 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.020 | 2 | 2012 | 2015 | ||||||
Adenoma
|
103 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.030 | 1.000 | 3 | 2008 | 2019 | |||||
Malignant neoplasm of stomach
|
615 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.030 | 0.667 | 3 | 2011 | 2017 | |||||
Stomach Carcinoma
|
652 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.030 | 0.667 | 3 | 2011 | 2017 | |||||
Breast Carcinoma
|
2793 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.040 | 0.750 | 4 | 2008 | 2016 | |||||
Carcinoma of lung
|
1204 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.040 | 1.000 | 4 | 2008 | 2017 | |||||
Malignant neoplasm of breast
|
3417 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.040 | 0.750 | 4 | 2008 | 2016 | |||||
Malignant neoplasm of lung
|
1142 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.040 | 1.000 | 4 | 2008 | 2017 | |||||
Primary malignant neoplasm of lung
|
981 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.040 | 1.000 | 4 | 2008 | 2017 | |||||
Malignant neoplasm of thyroid
|
103 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.050 | 1.000 | 5 | 2012 | 2017 | |||||
Thyroid carcinoma
|
145 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.050 | 1.000 | 5 | 2012 | 2017 | |||||
Thyroid Neoplasm
|
135 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.050 | 1.000 | 5 | 2012 | 2017 | |||||
Adenoma of large intestine
|
213 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.760 | 0.857 | 7 | 2010 | 2019 | |||||
Colon Carcinoma
|
275 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.070 | 1.000 | 7 | 2008 | 2013 | |||||
Neoplasms
|
1644 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.080 | 0.875 | 8 | 2009 | 2018 | |||||
Adenocarcinoma of large intestine
|
432 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.700 | 1.000 | 14 | 2007 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.578 | 0.440 | 8 | 127401060 | non coding transcript exon variant | G/T | snv | 0.37 | 0.700 | 1.000 | 14 | 2007 | 2019 |